Displaying 661 - 680 of 1043 results

NIAMS at AAD 2019

https://www.niams.nih.gov/es/node/6416

NIAMS at the American Academy of Dermatology 2019 Annual Meeting March 1 – 5, 2019 The following is a selection of presentations by NIAMS and NIAMS-supported researchers. Times are Eastern Standard Time. Friday, March 1 NIAMS Intramural Presentations F014 - Multidisciplinary Management of Chronic GVHD Friday, March 1, 9 –

Genomic Technology Section

https://www.niams.nih.gov/es/node/6456

The Genomic Technology Section helps NIAMS investigators solve highly diverse biological and biomedical research questions by providing a diverse portfolio of sequencing services as well as consultation and training for researchers with specific needs or challenging problems. It is a state-of-the-art laboratory facility equipped with the latest DNA sequencing and library preparation technologies.

FY 2020 Congressional Justification

https://www.niams.nih.gov/es/node/6551

March 2019 FY 2020 Congressional Justification PDF version (1 MB) DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Top NATIONAL INSTITUTES OF HEALTH National Institute of Arthritis and Musculoskeletal and Skin Diseases For carrying out section 301 and

Division of Extramural Activities

https://www.niams.nih.gov/es/node/6566

The Division of Extramural Activities (DEA) serves as a critical resource for our Extramural Programs, responsible for the areas of overall administration and management, scientific review, grants management, and clinical research administration. As a partner in the NIAMS mission, we promote the quality and impact of scientific research by assuring compliance with NIH and NIAMS policies and procedures in a transparent, consistent, fair and ethical manner. Specifically, the DEA:

Clinical Research Operations and Management Branch

https://www.niams.nih.gov/es/node/6571

The Clinical Research Operations and Management Branch (CROMB) has responsibility for assessing study risk, implementing data and safety monitoring oversight, tracking enrollment progress, and mitigating study related issues for the complete portfolio of NIAMS funded clinical trials and select human subjects observational studies with some level of risk (60-70 studies currently active in the managed portfolio). Specifically, this responsibility includes:

Administrative Management Branch - AMB-EP

https://www.niams.nih.gov/es/node/6586

The Administrative Management Branch (AMB) is located within the Office of the Director (OD) and is responsible for providing administrative and business management services to the NIAMS Office of the Director and the extramural programs. Administrative staff provide overall administrative support services in the areas of travel, procurement, personnel, budget, timekeeping, property, space, I.D. badges, parking, and general administration to its assigned areas efficiently and effectively to contribute to the mission of the NIAMS.

Scientific Review Branch - SRB

https://www.niams.nih.gov/es/node/6596

The Scientific Review Branch (SRB) is responsible for the initial scientific and technical merit review of grant applications submitted in response to NIAMS Requests for Applications (RFAs), Program Announcements (PARs), career (K) awards, R13 conference grants, clinical trials, and other special initiatives.

Typically materials from NIAMS that are more than 5 years old will be archived.